COMP <GO>
CEPL vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
Capstone Energy Plus Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CEPL 4
— TMO 7
■ METRIC PARITY
LAST: $2.63 (-5.05%) • MKT CAP: $90.3M
balance-sheet
—
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CEPL VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CEPL | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 59.30% | 9.30% | +50.00 | CEPL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 22.0x | 30.4x | -8.40 | CEPL | /valuation <GO> |
| Free Cash Flow Yield | -3.72% | 2.40% | -6.12 | TMO | /fcf-yield <GO> |
| Operating Margin | 3.20% | 17.40% | -14.20 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.60% | 15.10% | -12.50 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 23.90% | 3.90% | +20.00 | CEPL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.7 | 62.9 | -32.23 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.1x | 36.3x | -9.20 | CEPL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $90.3M | $262.22B | -$262.13B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CEPL REV | TMO REV | CEPL GROSS % | TMO GROSS % | CEPL FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $106.0M | $44.56B | 32.0% | — | -$3.4M | $6.29B |
| FY 2024 | $85.6M | $42.88B | 27.2% | — | $6.8M | $7.27B |
| FY 2023 | $91.2M | $42.86B | — | — | -$27.7M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CEPL // BETA —
TMO // BETA 0.94